Parallel Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.6M | Sell |
75,984
-2,490
| -3% | -$349K | 0.19% | 80 |
|
|
2025
Q4 | $9.63M | Buy |
78,474
+4,004
| +5% | +$487K | 0.18% | 86 |
|
|
2025
Q3 | $8.27M | Buy |
74,470
+39,239
| +111% | +$4.46M | 0.15% | 101 |
|
|
2025
Q2 | $3.91M | Buy |
35,231
+1,067
| +3% | +$114K | 0.08% | 175 |
|
|
2025
Q1 | $3.83M | Sell |
34,164
-2,876
| -8% | -$297K | 0.09% | 170 |
|
|
2024
Q4 | $3.42M | Sell |
37,040
-2,258
| -6% | -$203K | 0.08% | 187 |
|
|
2024
Q3 | $3.29M | Sell |
39,298
-18,825
| -32% | -$1.44M | 0.08% | 193 |
|
|
2024
Q2 | $3.99M | Buy |
58,123
+12,349
| +27% | +$824K | 0.1% | 152 |
|
|
2024
Q1 | $3.35M | Buy |
45,774
+2,438
| +6% | +$187K | 0.09% | 167 |
|
|
2023
Q4 | $3.51M | Buy |
43,336
+207
| +0.5% | +$16.1K | 0.1% | 151 |
|
|
2023
Q3 | $3.23M | Sell |
43,129
-1,421
| -3% | -$109K | 0.11% | 149 |
|
|
2023
Q2 | $3.43M | Buy |
44,550
+404
| +0.9% | +$32.2K | 0.11% | 148 |
|
|
2023
Q1 | $3.66M | Buy |
44,146
+1,908
| +5% | +$158K | 0.12% | 143 |
|
|
2022
Q4 | $3.63M | Sell |
42,238
-2,389
| -5% | -$189K | 0.16% | 99 |
|
|
2022
Q3 | $2.75M | Buy |
44,627
+7,680
| +21% | +$484K | 0.13% | 114 |
|
|
2022
Q2 | $2.28M | Buy |
36,947
+1,488
| +4% | +$92.1K | 0.1% | 131 |
|
|
2022
Q1 | $2.12M | Buy |
35,459
+2,205
| +7% | +$141K | 0.08% | 159 |
|
|
2021
Q4 | $2.42M | Buy |
33,254
+2,255
| +7% | +$155K | 0.09% | 149 |
|
|
2021
Q3 | $2.17M | Buy |
30,999
+1,657
| +6% | +$116K | 0.09% | 161 |
|
|
2021
Q2 | $2.02M | Buy |
29,342
+2,335
| +9% | +$156K | 0.09% | 161 |
|
|
2021
Q1 | $1.75M | Buy |
27,007
+821
| +3% | +$52.9K | 0.08% | 173 |
|
|
2020
Q4 | $1.53M | Sell |
26,186
-450
| -2% | -$27.2K | 0.08% | 166 |
|
|
2020
Q3 | $1.68M | Sell |
26,636
-1,801
| -6% | -$125K | 0.1% | 145 |
|
|
2020
Q2 | $2.19M | Buy |
28,437
+363
| +1% | +$27.8K | 0.14% | 111 |
|
|
2020
Q1 | $2.1M | Buy |
28,074
+3,005
| +12% | +$208K | 0.17% | 96 |
|
|
2019
Q4 | $1.63M | Sell |
25,069
-1,276
| -5% | -$83.1K | 0.12% | 133 |
|
|
2019
Q3 | $1.67M | Buy |
26,345
+150
| +0.6% | +$9.8K | 0.14% | 122 |
|
|
2019
Q2 | $1.77M | Buy |
26,195
+607
| +2% | +$39.9K | 0.17% | 104 |
|
|
2019
Q1 | $1.66M | Sell |
25,588
-116
| -0.5% | -$7.71K | 0.19% | 99 |
|
|
2018
Q4 | $1.61M | Sell |
25,704
-6,138
| -19% | -$429K | 0.22% | 84 |
|
|
2018
Q3 | $2.46M | Buy |
31,842
+25,900
| +436% | +$1.96M | 0.31% | 60 |
|
|
2018
Q2 | $420K | Sell |
5,942
-1,173
| -16% | -$82.8K | 0.06% | 208 |
|
|
2018
Q1 | $536K | Sell |
7,115
-178
| -2% | -$14.2K | 0.08% | 174 |
|
|
2017
Q4 | $522K | Buy |
7,293
+208
| +3% | +$15.8K | 0.09% | 166 |
|
|
2017
Q3 | $516K | Buy |
7,085
+147
| +2% | +$11.2K | 0.09% | 161 |
|
|
2017
Q2 | $528K | Buy |
6,938
+2,014
| +41% | +$134K | 0.1% | 156 |
|
|
2017
Q1 | $331K | Sell |
4,924
-4,244
| -46% | -$298K | 0.07% | 207 |
|
|
2016
Q4 | $657K | Buy |
+9,168
| New | +$681K | 0.15% | 113 |
|
Other funds holding GILD
VCM
VPM
Parallel Advisors's GILD Position: Q1 2026 in Review
Parallel Advisors reduced its Gilead Sciences (GILD) stake by 3.2% in Q1 2026, selling an estimated $349K and leaving 75,984 shares worth $10.6M. The position accounts for 0.19% of the portfolio, ranked #80.
Parallel Advisors first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Parallel Advisors held 75,984 shares of Gilead Sciences worth $10.6M as of Q1 2026.
- Parallel Advisors sold 2,490 Gilead Sciences shares in Q1 2026, an estimated $349K.
- Gilead Sciences made up 0.19% of Parallel Advisors's portfolio in Q1 2026, its #80 holding.
- Parallel Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.